RECORMON 4000 IU

국가: 이스라엘

언어: 영어

출처: Ministry of Health

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
10-05-2018
제품 특성 요약 제품 특성 요약 (SPC)
10-05-2018
공공 평가 보고서 공공 평가 보고서 (PAR)
17-08-2016

유효 성분:

EPOETIN BETA

제공처:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATC 코드:

B03XA01

약제 형태:

SOLUTION FOR INJECTION

구성:

EPOETIN BETA 4000 IU / 0.3 ML

관리 경로:

I.V, S.C

처방전 유형:

Required

Manufactured by:

ROCHE DIAGNOSTICS GmbH ,GERMANY

치료 그룹:

ERYTHROPOIETIN

치료 영역:

ERYTHROPOIETIN

치료 징후:

Treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. Treatment of symptomatic renal anemia in patients not yet undergoing dialysis. Increasing the yield of autologous blood from patients in a pre-donation program. Its use in this indication must be balanced against the reported increased risk of thromboembolic events. Treatment should only be given to patients with moderate anemia (Hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). Treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). Treatment of anemia in adult patients with multiple myeloma low grade non-Hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative erythropoietin deficiency and are receiving anti-tumor therapy.

승인 날짜:

2014-05-31

환자 정보 전단

                                •
كلهتسملل ةرشن
:ةوبعلا يف ةلومشم ريغ
•
لوحك ةدامض
•
مقعم شاش
•
ناتلمعتسملا ةنقحملاو ةربلإل نمآ
ءاقللإ ةنمآو ةبلص ةبلع
ةنقحلا ريضحت
1
.
.داربلا جراخ ةربلإاو ةنقحملا عم
نوتركلا ةوبع جرخأ .يوتسمو فيظن ،ءاضم
لمع حطس رايتخاب مق
2
.
تطقس اذإ ،ةيحلاصلا تذفن اذإ ءاودلا
لامعتسا زوجي لا .ةوبعلا رهظ ىلع ددحملا
ةيحلاصلا خيرات ءاهتنا مدع نم دكأتو
ةوبعلا ررضت مدع نم دكأت
.كجلاعي يذلا يبطلا مقاطلا عم لصاوتو 17
ةلحرملا ىتح لمكأ ،ةلاحلا هذه يف
.ةررضتم نوتركلا ةوبع نأ كل ادب اذإ وأ
تررضت وأ ةنقحملا
3
.
رهاظ وه امك ةنقحملا كسمت كنأ نم دكأت
.ةنقحملا جارخإ دنع رذحلا يخوت بجي
.ةربلإا ةبلع نم ةدحاو ةربإو نوتركلا
ةوبع نم ةدحاو ةنقحم جرخأ
.هاندأ ةروصلا يف
•
.ةنقحملا جارخإ لجأ نم ةوبعلا بل
ْ
قَ زوجي لا
•
.ةربلإا ءاطغ وأ سبكملا نم ةنقحملا
كاسمإ زوجي لا
•
.داربلا ىلإ ةيقبتملا ربلإاو نقاحملا عم
نوتركلا ةوبع ةداعإب مق ،ةوبعلا لخاد
نقاحم تقبت اذإ
4
.
.ةيانعب ةربلإاو ةنقحملا صحفا
•
.ا
ً
ررضتم ودبي ةنقحملا نم ءزج ناك اذإ وأ
تطقس يتلا ةنقحم لامعتسا زوجي لا
.ةربلإاو ةنقحملا ررضت مدعو ةملاس نم
دكأت
•
.ةيحلاصلا تذفن اذإ ةربلإا وأ ةنقحملا
لامعتسا زوجي لا .ةربلإاو ةنقحملا رهظ
ىلع ةيحلاصلا ءاهتنا خيرات نم دكأت
•
وأ هنول ريغت اذإ ،ا
ً
ركع لولحملا ناك اذإ ةنقحملا ل
                                
                                전체 문서 읽기
                                
                            

제품 특성 요약

                                Page 1 of 12
Ref: EU SPC and PIL EMEA/H/C/000116/IAIN/0097
Recormon_PI_Ver.2.0
_ _
Recormon_PI_Version 2.0
The content of this leaflet was approved by the Ministry of Health in
January 2016 and updated
according to the guidelines of the Ministry of Health in April 2018
RECORMON
®

_ _
_Epoetin beta _
PRE-FILLED SYRINGE FOR SUBCUTANEOUS OR INTRAVENOUS INJECTION
_ _
1.
NAME OF THE MEDICINAL PRODUCT
RECORMON

4000 IU SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
RECORMON

5000 IU SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
RECORMON

6000 IU SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
RECORMON

10,000 IU SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
RECORMON

30,000 IU SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Recormon 4000 IU solution for injection in pre-filled syringe
One pre-filled syringe with 0.3 ml solution for injection contains
4000 international units (IU) corresponding to 33.2
micrograms epoetin beta)/, * (recombinant human erythropoietin).
One ml solution for injection contains 13,333 IU epoetin beta.
Recormon 5000 IU solution for injection in pre-filled syringe
One pre-filled syringe with 0.3 ml solution for injection contains
5000 international units (IU) corresponding to 41.5
micrograms epoetin beta/ * (recombinant human erythropoietin).
One ml solution for injection contains 16,667 IU epoetin beta
Recormon 6000 IU solution for injection in pre-filled syringe
One pre-filled syringe with 0.3 ml solution for injection contains
6000 international units (IU) corresponding to 49.8
micrograms epoetin beta, * (recombinant human erythropoietin). One ml
solution for injection contains 20,000 IU
epoetin beta.
Recormon 10,000 IU solution for injection in pre-filled syringe
One pre-filled syringe with 0.6 ml solution for injection contains
10,000 international units (IU) corresponding to 83
micrograms epoetin beta * (recombinant human erythropoietin). One ml
solution for injection contains 16,667 IU
epoetin beta.
Recormon 30,000 IU solution for inje
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 아랍어 04-10-2018
환자 정보 전단 환자 정보 전단 히브리어 04-10-2018

이 제품과 관련된 검색 알림